1 completed, 1 terminated, 1 withdrawn. 2 Early Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Idazoxan: new trials by email Literature Review of Idazoxan trials Research Report on Idazoxan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| I2PETPG - Imidazoline2 Binding Sites in a Group of Participants Diagnosed With AD [11C]BU99008, Idazoxan - Alzheimer Disease | Early Phase 1 | Terminated | Imperial College London | 2 | 2016-07-01 | 2020-08-27 |
| I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers [11C]BU99008, Idazoxan, Isocarboxazid - Healthy Volunteers, Alzheimer Disease | Early Phase 1 | Completed | Imperial College London | 20 | 2015-01-01 | 2021-11-15 |
| The Effectiveness of Idazoxan in Treating TRD Idazoxan - Major Depressive Disorder | Phase 3 | Withdrawn | Sheba Medical Center | 2008-01-29 |
Alzheimer Disease (2) · Depressive Disorder, Major (1)
Imperial College London (2) · Sheba Medical Center (1)
United Kingdom (2) · Israel (1)
David J Nutt, MD (2) · Joseph Zohar, MD (1)